Thus, in vitro studies are a limitation to investigate the effect of FHR-3 on bacterial infections and future studies should focus on the use of P. aeruginosa Cfhr-3 knock-out mice model of infection to evaluate the role of this complement regulator factor in vivo. The gene discussed is CFHR3; the disease is bacterial infectious disease.